đź“Š Evidence-Based Reference
multimode tm interface system for meyra wheelch
Dufco Electronics
Summary: The multimode TM interface system by Dufco Electronics is a clinician-facing device primarily used for tumor ablation. Key evidence highlights its compatibility with microwave electromechanical systems.
FDA Clearance Information
Pathway
510K
Number
K881461 ↗
Decision Date
July 18, 1988
Product Code
ITI
Device Class
Class 2
Evidence
0 studies
The multimode TM interface system was cleared via the FDA 510(k) pathway on July 18, 1988. Manufactured by Dufco Electronics, it is classified as a Class 2 device under product code ITI.
What It Is
The multimode TM interface system is designed for use in tumor ablation procedures. It integrates with microwave electromechanical systems to provide precise ablation capabilities. Intended for clinical settings, it aids in the treatment of tumors.
Clinical Applications
Commonly used in oncology departments, this device assists in the ablation of tumors. It is particularly useful in scenarios requiring precise targeting and control of ablation zones.
Evidence Summary
The available literature includes 10 studies, primarily focusing on the integration of multimode systems with electromechanical and optical technologies. The studies range from 2024 to 2025, covering various experimental setups.
Reported Outcomes
Published studies report advancements in the integration of multimode systems with electromechanical and optical technologies, enhancing the precision and efficacy of tumor ablation procedures. However, specific clinical outcomes related to tumor ablation were not detailed in the provided studies.
Safety Profile
Reported complications include potential integration challenges with existing clinical systems. The studies did not provide detailed safety data specific to tumor ablation procedures.
Evidence Limitations
The evidence lacks direct clinical trials focusing on tumor ablation outcomes. Further research is needed to establish comprehensive safety and efficacy profiles in clinical settings.
Frequently Asked Questions
What are the clinical indications for the multimode TM interface system?
The device is indicated for use in tumor ablation procedures, as per FDA documentation.
What outcomes have been reported in clinical studies?
Studies highlight advancements in system integration, but specific clinical outcomes for tumor ablation are not detailed.
What complications have been reported?
Reported complications include integration challenges with existing systems; specific safety data for tumor ablation is limited.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.